Procedure

2020 discharge: European Medicines Agency (EMA)

2021/2132(DEC)·9th term·ENVI·DEC - Discharge procedure·CompletedProcedure completed

Subjects: 2020 discharge

Rapporteur (the Member appointed to lead Parliament's work on this text): ZDECHOVSKÝ Tomáš (EPP)

Summary

A discharge decision on the European Medicines Agency for the financial year 2020. The amendments emphasise the EMA's role in assessing the quality, safety and efficacy of medicines, the impact of the COVID-19 pandemic, transparency and independence given largely private funding, fee waivers for COVID-19 and orphan medicines, the relocation to Amsterdam after the United Kingdom's withdrawal, staff shortages and the proposed mandate extension, medicine shortages, and antimicrobial resistance.

Procedure timeline

Committee amendments tabled
8 Dec 2021
Plenary vote — Passed
4 May 2022 · On the motion for a resolution — the text as a whole
Procedure completed

Amendments

distinct, in window

Members

tabled at least one

Committee(s)

8 Dec 2021

Dates

Plenary votes

1 roll-call votes

In plenary, Parliament usually votes in steps: first on amendments to the text (sometimes split into parts, so Members can accept one half of a sentence and reject the other), then on the text as a whole. The “main vote” is the one that adopts or rejects the text itself. Each vote below shows exactly which step it was. How voting works →

4 May 2022Main votePassedoutcome from totals
On the motion for a resolution — the text as a whole
Official label: Proposition de résolution (ensemble du texte) · what was voted ↗
559 for55 against27 abstentions64 did not vote
For
Against
Abst.
Click a group to see each Member’s position.